e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
COPD: epidemiology and varia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is high level of IgE an additional problem in smoking patients with severe and very severe chronic obstructive pulmonary disease (COPD)?
N. Slepchenko, Y. Mostovoy, A. Sidorov (Vinnitsa, Ukraine)
Source:
Annual Congress 2012 - COPD: epidemiology and varia
Session:
COPD: epidemiology and varia
Session type:
Thematic Poster Session
Number:
3441
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Slepchenko, Y. Mostovoy, A. Sidorov (Vinnitsa, Ukraine). Is high level of IgE an additional problem in smoking patients with severe and very severe chronic obstructive pulmonary disease (COPD)?. Eur Respir J 2012; 40: Suppl. 56, 3441
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…
Related content which might interest you:
Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001
Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Active smoking negatively affects recovery of patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions
Year: 2011
The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Anxiety and low health status are predictors of exacerbations in patients with obstructive pulmonary disease
Source: Annual Congress 2006 - Muscles, training and rehabilitation
Year: 2006
The food frequency in patients with chronic obstructive pulmonary disease: effect of exacerbation of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006
Smoking abstinence in patients with chronic airway obstructive disease
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006
Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links?
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007
Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Characteristics and comorbidities associated with pain in people with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
Detection of asthma and chronic obstructive pulmonary disease in primary care
Source: Eur Respir J 2003; 21: 16S-22S
Year: 2003
Does chronic obstructive pulmonary disease (COPD) impact on women smoking cessation approach?
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018
Are severe asthma and chronic obstructive pulmonary disease the same disease?
Source: Annual Congress 2006 - Smoking asthmatics – a neglected population?
Year: 2006
Functional status in high and low risk patient with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD
Year: 2013
Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Clinical determinants of exacerbations in severe, early-onset COPD
Source: Eur Respir J 2007; 30: 1124-1130
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept